Paper Details

  1. Home
  2. Paper Details

Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer-A Literature Review.

Author: Amir CarmonaCarlos, EisenAndrea, MataDanilo Giffoni de Mello Morais, TrudeauMaureen

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discusses adjuvant endocrine therapy (ET) for ER+ HER2- breast cancer (BC), outlining suitable treatment strategies and guiding clinical decision-making around appropriate therapy.
Paper Details　
Original Abstract of the Article :
Approximately 75% of breast cancer (BC) is associated with luminal differentiation expressing endocrine receptors (ER). For ER+ HER2- tumors, adjuvant endocrine therapy (ET) is the cornerstone treatment. Although relapse events steadily continue, the ET benefits translate to dramatically lengthen li...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320044/

データ提供：米国国立医学図書館（NLM）

Endocrine Therapy: A Beacon of Hope for Breast Cancer

Breast cancer, a complex and challenging disease, is like a vast desert where the journey can be long and uncertain. This study explores the role of adjuvant endocrine therapy (ET) in the treatment of hormone receptor-positive HER2-negative breast cancer, like a traveler seeking guidance on a treacherous path.

The Power of Endocrine Therapy

The study highlights the critical role of ET in extending the lives of patients with this type of breast cancer. It’s like finding a hidden oasis that provides nourishment and respite along the journey. ET has proven to be a valuable tool in the fight against breast cancer.

A Guide for Treatment Decisions

This study provides a comprehensive overview of current treatment strategies for ER+ HER2- breast cancer, offering guidance for clinicians in making informed treatment decisions. It's like having a map that guides us through the complex landscape of this disease.

Dr.Camel's Conclusion

This research underscores the remarkable progress made in the treatment of breast cancer, particularly for hormone receptor-positive tumors. Endocrine therapy has emerged as a powerful weapon in this fight, offering hope and extending the lives of countless patients. This study serves as a reminder that we must continue to explore new frontiers in cancer research and development, seeking innovative solutions that can conquer this challenging disease.
Date :
  1. Date Completed 2022-07-27
  2. Date Revised 2022-09-08
Further Info :

Pubmed ID

35877254

DOI: Digital Object Identifier

PMC9320044

Related Literature

Article Analysis
・Side Effects of abemaciclib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.